에이스헬스케어

비상장계속사업자

Ace Healthcare. Co.,Ltd

이지희

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

에이스헬스케어

Business Reg. No. 3628602458 · CEO 이지희

I.Investment Overview

Target에이스헬스케어 (3628602458)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명에이스헬스케어
영문명Ace Healthcare. Co.,Ltd
대표자이지희
사업자등록번호3628602458
법인등록번호1542110027177
설립일2022.04.04
종업원수171명

V.Workforce

171

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW183.120222582023238.52024270.42025
영업이익100M KRW31.3202239.1202331.8202447.82025
순이익100M KRW32.9202241.1202329.2202444.12025
Item2025202420232022
자산총계464.5억원390.7억원353.7억원305.5억원
부채총계89.4억원48.8억원37.1억원30억원
자본총계375.1억원341.9억원316.6억원275.5억원
매출액270.4억원238.5억원258억원183.1억원
영업이익47.8억원31.8억원39.1억원31.3억원
순이익44.1억원29.2억원41.1억원32.9억원

VII.Financial Ratios

FY2025 basis

17.68%

영업이익률

16.32%

순이익률

9.5%

ROA

11.76%

ROE

23.84%

부채비율

80.75%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

에이스헬스케어 투심보고서 | Alpha Lenz